Pancreatic eicosapeptide is synthesized together with the hormone pancreatic polypeptide in a common precursor in the major endocrine cell type of the duodenal pancreas. This processing has been previously demonstrated in man and in the dog. In the present study the cat pancreatic eicosapeptide and a C-terminally extended form of this were isolated and characterized from acid/ethanol extracts of pancreas by gel filtration and reverse-phase h.p.l.c. The sequence homology in the C-terminal part of the eicosapeptides from different species was shown to continue to the other side of the monobasic cleavage site in the extended intermediate form, whereas the end of the extension differed both in chain length and amino acid sequence. It is concluded that the processing site in the intermediate form of the pancreatic eicosapeptide is an example of a proline-directed monobasic cleavage site that has been conserved during evolution.
INTRODUCTION
The pancreatic polypeptide family of regulatory peptides currently.consists ofthree homologous peptides:
pancreatic polypeptide (PP) , neuropeptide Y (NPY) and peptide YY (PYY). All three peptides consist of 36 amino acid residues with a C-terminal tyrosine (Y) amide residue. NPY is an important neuropeptide in the central and peripheral nervous systems. It is often located and functioning together with noradrenaline (norepinephrine) (Tatemoto, 1982a) . PYY is a hormone located predominantly in the distal small intestine (Tatemoto, 1982b) . PP, the oldest recognized member of the family, is a hormone released from the major endocrine cell type of the duodenal pancreas and regulates pancreatic exocrine secretion and biliary tract motility (Schwartz, 1983) . PP is co-synthesized with another peptide product, pancreatic eicosapeptide (20 amino acids), on a common precursor (Schwartz et al., 1980; Schwartz & Tager, 1981) . The precursor is relatively small, comprising only an additional oligopeptide offive to seven amino acid residues in addition to a signal peptide of 29 amino acid residues, which gives a total of 95 amino acid residues (Boel et al., 1984; Leiter et al., 1984; Takeuchi & Yamada, 1985) . The precursor for NPY is homologous to the PP precursor with a C-terminal extension of similar size but not obviously homologous in primary structure to the eicosapeptide part of the pancreatic polypeptide precursor (Minth et al., 1984) . Processing of precursors for regulatory peptides generally occurs at dibasic sequences, as originally outlined by Steiner et al. (1974) . However, within recent years it has become evident that single basic residues can also serve as processing sites (Schwartz, 1986) . The common precursor for PP and pancreatic eicosapeptide is cleaved both at a dibasic site, between the two peptides, and at a monobasic site, after the eicosapeptide, as studied in detail in dog endocrine cells (Schwartz et al., 1980; Schwartz & Tager, 1981 ; T. W. Schwartz, unpublished work) . In order to determine to what degree the monobasic cleavage site has been conserved during evolution, in the present study we have isolated and characterized the pancreatic eicosapeptide and its biosynthetic intermediate form from cat pancreas.
MATERIALS AND METHODS Peptide isolation
The duodenal part of cat pancreas was excised within 30 min post mortem. The tissue (60 g from nine cats) was frozen on solid CO2 and stored at -80 'C. It was broken into small pieces and homogenized in a Braun blender in cold acidified ethanol [final concentrations 68% (v/v) ethanol and 0.1 M-HCI) at -20 'C. Homogenization was continued intermittently until the temperature reached 4°C. The homogenate was incubated overnight at 4 'C and then centrifuged at 10000 g for 30 min at the same temperature in a Sorval RC-5B High Speed centrifuge with a GSA rotor. The supernatant was neutralized with 25% (v/v) NH3 and centrifuged at 5000 g for 5 min at 4 'C in the same rotor and centrifuge. Proteins in the new supernatant were precipitated by adding 2 vol. of ethanol and 4 vol. of diethyl ether. The precipitate that formed during incubation overnight at 4 'C was dried under N2 and reconstituted in 10 ml of 1 M-acetic acid. The extract was gel-filtered on a 2.5 cm x 95 cm column of Sephadex G-50 (superfine grade) (Pharmacia, Sweden) eluted with 1 M-acetic acid at 4 'C at a flow of 28 ml/h. Absorption at 280 nm was determined in the 7 ml fractions, and samples from selected fractions were analysed on an h.p. Applied Biosystems) for 10 min at 50 'C. Aminobutyric acid was used as internal standard during the h.p.l.c. for correction of elution time and for quantifying the amino acid derivatives.
RESULTS
Analytical h.p.l.c. of selected fractions from the gel filtration ofpeptides, obtained by acid/ethanol extraction and ether precipitation of cat duodenal pancreas, indicated that a peptide similar to the dog pancreatic eicosapeptide was eluted in a peak distinct from the PP peak during gel filtration (Fig. la) . Fractions corresponding to this peak, fractions 82-86 (II), and those immediately before, fractions 78-81 (I), were pooled. As demonstrated in Fig. 1 , pool II contained only one major peptide, indicated by the open arrow, which by sequence determination was shown to be homologous to the previously characterized pancreatic eicosapeptides. This peptide could also be identified in pool I, in which a minor peptide peak (indicated by the closed black arrow) by sequence determination was shown to have the same N-terminal sequence but to be extended by seven amino acid residues in its C-terminal end. This peptide is homologous to the biosynthetic intermediate form were treated with trypsin, and the fragments were purified by h.p.l.c. as in Fig. 1 limit the degradation to the C-terminal end (Hayashi et al., 1975 The open arrow indicates the monobasic cleavage site and the solid black arrow indicates the dibasic cleavage site. Asterisks indicate the location of introns in the human gene (Leiter et al., 1985) . The structure of the human propeptide is both deduced from a cDNA sequence (Boel et al., 1984) and determined by peptide chemistry characterization of the main peptides (Chance et al., 1979; . The question mark in the C-terminal end of the sheep precursor indicates the presence of a probable extension. However, only the structure of the eicosapeptide itself has been determined . The PP sequences have all been determined by Chance et al. (1979) , except for that of the cat, which was performed along with the present study (isolated from the peptide pool indicated with an open bar in Fig. 1 ; detailed results not presented). Below, the cDNA-deduced sequence of the human neuropeptide Y (NPY) propeptide is shown (Minth et al., 1984) , in which the open arrow with the question mark indicates the presence of a suggested 'proline-directed arginine cleavage' site. The one-letter code for amino acids is used.
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The sequence of the cat eicosapeptide is very similar to that of the dog counterpart, the only differences being in positions 5 and 6 (Fig. 3) . On -the other hand, the C-terminal extension of the intermediate form varies with respect to sequence and length, i.e. seven amino acid residues in cat and man but only five in the dog. However, the amino acid sequence surrounding the monobasic cleavage site in the intermediate form, -Pro-Arg-Glu-Leu-, is conserved in all species studied (Fig. 3) .
DISCUSSION
In the present study the pancreatic eicosapeptide and a C-terminally extended form of this peptide were isolated and characterized from cat pancreas. The C-terminally extended form is homologous to a biosynthetic intermediate of the eicosapeptide that has been characterized in pulse-chase experiments in isolated endocrine cells from dog pancreas (Schwartz & Tager, 1981; T. W. Schwartz, unpublished work) . In previous studies we have shown that the pancreatic eicosapeptide itself is more highly conserved during evolution in its C-terminal region than in its N-terminal region (Schwartz & Tager, 1981; . By comparing the intermediate forms from different species, it appears that conservation of primary structure in the C-terminal end continues to the other side of the monobasic processing site. Thereafter distinct differences are observed in chain length and amino acid sequences (Fig. 3) . Apparently, the structural basis for the generation of the eicosapeptide from the PP precursor through a monobasic processing mechanism has been conserved. It may be of significance that one of the intervening sequences in the PP gene is located just in this monobasic cleavage site (indicated with an asterisk in Fig 3) . The other intron in the coding sequence is located just before the dibasic processing site (Leiter et al., 1985) . The introns thus separate structural domains that eventually will be released as distinct peptides.
The eicosapeptide is a secretory product from the PP cell, but no convincing biological effect has yet been attached to it. It is possible, however, that the monobasic cleavage site at this location in the precursor actually is of greater importance in other members of the PP peptide family, e.g. in the precursor for NPY. Here a similar site for 'proline-directed arginine cleavage' (see below) is found at almost t6e same place in the homologous precursor although there is little similarity in the primary structure in this part of the precursor (Fig.  3) . Thus it could be suggested that the cleavage site could have been conserved in order to ensure the correct production of another peptide also ending in Pro-Arg Fig. 4 . Monobasic processing sites with adjacent proline residues in precursors for regulatory peptides The main peptide product is indicated by an open box and its name is shown to the left. Adjacent proline residues are underlined. Arrows indicate the putative initial cleavage site. Information concerning the precursor structure, the specific cleavage site-or -the-peptide are from pancreatic eicosapeptide (the present study), yeast killer toxin (Bostian et al., 1984) , gastrin-releasing peptide (Reeve et al., 1983) , atrial natriuretic polypeptide (Kangawa et al., 1984) , secapin (Vlasak & Kreil, 1984) , adrenorphin (Matsuo et al., 1983) , dynorphin A (Cone et al., 1983), substance P (Nawa et al., 1983) , human relaxin (Hudson et al., 1983) and corticotropin-like intermediate-lobe peptide (CLIP) (Nakanishi et al., 1979) .
but co-synthesized and possibly co-functioning with NPY.
The main processing sites for peptide precursors are pairs of basic residues (Steiner et al., 1974) . However, as recently reviewed, the rapidly growing knowledge of precursor structure obtained mainly through deduction from cDNA sequences has revealed that cleavage at single basic residues is also fairly common (Schwartz, 1986a) . In PP cells in culture it is possible to distinguish between the monobasic cleavage mechanism, which occurs late in the biosynthetic process and is lost during the first 24-48 h of culture, and dibasic processing, which occurs early and is retained even after 10 days of culture (T. W. Schwartz, unpublished work). In about one-third of cases of monobasic cleavage, the basic residue is either preceded or followed by a proline residue (Fig. 4) . If the sequence is Pro-Arg, the scissile bond is the one on the C-terminal side of the arginine residue, but it is on the N-terminal side if the sequence is Arg-Pro. The special conformational constraint, induced by proline residues on the peptide backbone, has led to the suggestion that the three-dimensional structure is particularly important for the processing at single basic residues (Schwartz, 1986) . As shown in Fig. 4 , such 'proline-directed arginine cleavage' is found even in yeast (Bostian et al., 1984) , and in the present investigation evidence is presented that a particular monobasic site in the intermediate form of pancreatic eicosapeptide is highly conserved among different mammalian species.
